Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Filings indexed 992 across all filing types
Latest filing 2025-11-06 Major Shareholding Noti…
Country FI Finland
Listing HE BIOBV

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj - Notification Pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in significant share ownership (flagging notification) for Biohit Oyj, specifically citing Chapter 9, Section 10 of the Finnish Securities Markets Act. This type of disclosure, where a shareholder crosses a specific percentage threshold of shares and voting rights, is classified as a Major Shareholding Notification.
2025-11-06 English
Biohit Oyj:n B-osakkeiden merkintä optio-oikeuksilla I 2021C ja I 2022C
Share Issue/Capital Change Classification · 100% confidence The document announces the subscription of new B-shares in Biohit Oyj using option rights (I 2021C and I 2022C). It details the number of shares issued, the subscription price, the impact on the total number of shares, and the registration of these shares in the trade register. This falls under the category of share issuance and capital changes.
2025-10-10 Finnish
Biohit Plc B-shares Subscribed with Stock Options I 2021C and I 2022C
Share Issue/Capital Change Classification · 100% confidence The document is a stock exchange release announcing the subscription of new B-shares via stock options. This involves an increase in the total number of shares and capital changes, which falls under the category of share issues or capital changes.
2025-10-10 English
Biohit Oyj - Johdon liiketoimet - Hendolin
Director's Dealing Classification · 100% confidence The document is titled 'Johdon liiketoimet' (Management Transactions) and details a specific share transaction (subscription/exercise of options) by a member of the senior management (Panu Hendolin) of Biohit Oyj. This matches the definition for Director's Dealing (DIRS), which covers personal share transactions by company executives.
2025-09-11 Finnish
Biohit Plc - Managers' transactions - Hendolin
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction in shares by a senior manager (Panu Hendolin) of Biohit Plc. It includes specific details such as the person's position, the nature of the transaction (subscription linked to a stock option programme), the volume, and the price. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-09-11 English
BIOHIT-KONSERNIN PUOLIVUOSIKATSAUS 1.1.-30.6.2025 (tilintarkastamaton)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj covering the period 1.1.-30.6.2025. It contains comprehensive financial statements, key performance indicators, management commentary, and operational updates. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2025
2025-08-06 Finnish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.